CTRI/2014/10/005150已完成4 期
A RANDOMISED CONTROLLED COMPARATIVE OPEN LABEL TRIAL ON THE SAFETY AND EFFICACY OF BACLOFEN WITH THAT OF DIAZEPAM IN SPASTICITY DUE TO ACQUIRED SPINAL CORD INJURIES
GOVERNMENT MEDICAL COLLEGEKOZHIKODE0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Written informed consent
- •2.Age 18 years and above
- •3.Patients after two months of spinal cord injury with established spasticity and not in spinal shock
- •4.Spasticity due to spinal cord injury of all grades
- •5.Spasticity interfering with sleep and functional capacity
排除标准
- •1.Significant history of Hypersensitivity to the study drugs
- •2.Respiratory disorders like COPD, Sleep apnoea
- •3.Chronic liver disease
- •4.Renal disease
- •5.With psychiatric illness of any kind
- •6.Broken skin and any infections trigerring spasticity
- •7.Patients receiving drugs interfering significantly with the study drugs
- •8.Patients planned for surgical intervention
- •9.Glaucoma
- •10.Myasthenia gravis
研究者
相似试验
尚未招募
3 期
A Study To Assess The Role Of Indicated Homoeopathic Medicine In Restoring Regular Menstrual Cycle In Cases Of PCODCTRI/2023/06/054082Dr MPK Homoeopathic Medical College Hospital and Research Centre
尚未招募
不适用
Pre-emptive steroids to alter the disease course in COVID-19 patientsCTRI/2021/05/033873JK Hospital and LN Medical College
已完成
不适用
A Prospective, Concurrent Controlled, Open-Label, Multicenter Clinical Study to Assess the Long-Term Safety of the PRESERFLO® MicroShunt in Subjects with Primary Open-Angle Glaucoma Who Have Completed Participation in the INN-005 Randomized Controlled Study.intraocular pressurelowering the pressure in the eye10018307NL-OMON55019InnFocus, Inc18
已完成
3 期
A clinical trial to study the efficacy ,safety and tolerability of halometasone + fusidic acid in comparison with betamethasone + neomycin sulphate in the treatment of infected eczematous dermatititis.CTRI/2009/091/000039Dr Reddys Laboratories Ltd150
进行中（未招募）
1 期
A PROSPECTIVE, RANDOMIZED, OPEN-LABEL, COMPARATIVE STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF AZTREONAM-AVIBACTAM (ATM-AVI) AND BEST AVAILABLE THERAPY FOR THE TREATMENT OF SERIOUS INFECTIONS DUE TO MULTI-DRUG RESISTANT GRAM- NEGATIVE BACTERIA PRODUCING METALLO-?-LACTAMASE (MBL)SERIOUS INFECTIONS DUE TO MULTI-DRUG RESISTANT GRAM- NEGATIVE BACTERIA PRODUCING METALLO-?-LACTAMASE (MBL)MedDRA version: 20.0Level: LLTClassification code 10021804Term: Infection bacterialSystem Organ Class: 100000004862EUCTR2017-004544-38-GRPfizer Inc.60